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Summary Glomerular filtration rate (GFR), '3'I-Hippuran clearance and estimated creatinine clearance were
investigated in 34 patients with cancer. For Hippuran clearance and GFR, analysed with the X-ray contrast
(iohexol) and fluorescence technique, the least square linear regression coefficient was 5.01 ± 0.41 (r = 0.91).
This value concurs with the five to one ratio between GFR and renal plasma flow known from normal
physiology and supports that Hippuran clearance is a valid measure of renal function. When the individual
values of Hippuran clearance were divided by 5.01, the mean difference between the methods was
0.4 ml min' 1.73 m2 with standard deviation 13.4 ml min-' 1.73m2. The lower and upper limits of agree-
ment were - 26.7 and 25.9 mlmin-' 1.73m2, respectively. Comparing creatinine clearance estimated from
the serum creatinine level with GFR, the limits of agreement were - 29.4 and 21.6 ml min-' 1.73 m-2. These
agreement limits are in the same range as those which can be calculated from the data from other studies.
Knowledge of the renal function is important in patients
scheduled for potentially nephrotoxic treatment. Investiga-
tions allowing concurrent functional assessment and urinary
tract imaging have a particular role in the management of
patients with urogenital cancer in whom obstruction of the
upper urothelial tract is a special risk. This goal is achieved
with '3'I-labelled Hippuran which has been the routine
method for renal function studies in our department. The
Hippuran clearance provides an estimate of glomerular filtra-
tion and tubular secretion (Ganong, 1977).
The glomerular filtration rate (GFR), however, seems to be
the kidney function variable used most commonly in clinical
oncology. GFR can be measured from the clearance ofX-ray
contrast media (Gronberg et al., 1983; Sj6berg et al., 1987;
Effers6e et al., 1990). Combining X-ray investigation using
contrast media and GFR measurement seems attractive from
a clinical point of view.
The present study was conducted in a series of 34 patients
with cancer (33 with urogenital cancer). The study objective
was to compare Hippuran clearance and creatinine clearance
estimated from serum creatinine values with the GFR
assessed with iohexol fluorescence technique.
Patients and methods
Between November 1989 and April 1990, 35 consecutive
cancer patients underwent investigations of glomerular filtra-
tion rate (GFR) using iohexol fluorescence technique, and
Hippuran clearance. In one patient with testicular cancer, the
blood samples for the Hippuran clearance measurement was
contaminated with the radiotracer. This patient was ex-
cluded, leaving 34 patients for evaluation (Table I). All were
normotensive without known glomerular disease and none
had previously received cytotoxic therapy. None had serum
creatinine levels >300g.moll1' (upper limit 125iLmollh'),
clinical signs of oedema, ascites, or pleural effusion, or
known allergic disorder. The protocol included two blood
samples for serum creatinine measurement, one obtained
concurrently with the GFR investigation and one obtained
previously, usually on the day of admission. The protocol
was approved by the regional ethical committee in medical
research. All patients gave informed consent to participate.
Serum creatinine
This was analysed using the Jaffe reaction. The day to day
coefficient of variation was <3.5% during the study. These
data were used to estimate creatinine clearance using Cock-
roft's formula, modified for SI units and normalised to
mlmin -' 1.73 m2 body surface (Cockroft & Gault, 1976;
Lott & Hayton, 1978). This formula reads:
(I140 - age) a 2.12 a weight o K
Creatinine clearance (mlmin- 1.73m 2)=(10ae.2.12wih serum creatnine . body surface
with serum creatinine in jsmol 1', age in years, weight in kg,
body surface in square metres. The constant K is 0.85 for
women and 1.00 for men.
'31I-Hippuran clearance
This was measured using the Oberhausen method (Ober-
hausen, 1977). The patients drank 500 ml of water before the
investigation. To avoid vasovagal episodes during the 30 min
of data acquisition, the patients were kept in the supine
position. The blood pressure was measured repeatedly. No
changes outside ± 10% of the initial value occurred. Five
MBq 311-Hippuran (Institutt for Energiteknikk, Kjeller, Nor-
way) dissolved in 2 ml normal saline was injected in an
indwelling cannula followed by 20ml normal saline. Blood
samples were taken from the same cannula 15 and 25 min
after the injection. Renograms, split kidney function, and
total Hippuran clearance were calculated by a manufacturer-
supplied computer software (Siemens/Searle, Sonntag
(1983)).
Glomerularfiltration rate (GFR) using iohexol and
fluorescence technique
The injection of iohexol followed immediately after finishing
the Hippuran study. The indwelling cannula was finally
Table I Summary of 34 patients with urogenital cancer
No. Age
Diagnosis (patients) median (range)
Bladder ca. 14 (3)* 73 (50-80)
Testicular ca. 12 (-) 39 (18-61)
Renal ca. 4 (1) 59.5 (58-73)
Prostatic ca. 3 (-) 67 (63-71)
Myelomatosis I (-) 59
Total 34 (4) 62 (18-80)
*Number of females in parenthesis.
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flushed with 20 ml saline. The patients then returned to the
ward. No food, fluid or smoking restrictions were issued. The
individual iohexol dose (Omnipaque 350 mg iodine per ml,
Nycomed, Oslo, Norway), ranged from 4 to 30 ml, and was
determined from the patient's estimated creatinine clearance
and body weight, using a nomogram supplied by the
manufacturer.
Serum concentrations of iohexol were determined using an
iodine fluorescence analyser (Renalyser PRX90, Provalid AB,
Lund, Sweden). The method has been described elsewhere
(Gronberg et al., 1983; Sjoberg et al., 1987). When the study
started, no recommendation concerning the best sampling
time for a one-point GFR determination was available. Sam-
ples were therefore drawn from the indwelling cannula after
about 2, 3 and 4 h in patients with estimated creatinine
clearance < 100 ml min-' 1.73 m-2, and after about 1, 2 and
3 h in patients with estimated clearance > 100 ml min
-11.73 m-2. The samples were frozen and analysed in one
batch at the end of the study when a software option pro-
viding a recommended sampling time for one-point analysis
given the patient's serum creatinine, age, weight and height
had become available. The sample obtained nearest to this
recommended time was used for one point GFR estimation
(GFR1). Data from all three samples were used to obtain the
GFR slope (GFR3).
Data analysis
The data are presented as means with standard errors (SEM),
unless otherwise is stated. Commercially available microcom-
puter software was used. The mean difference (D) between
selected variables and the standard deviation of the
differences (SD) were calculated. With differences approxi-
mately normally distributed, 95% of the differences will lie
between D-1.96*SD and D + 1.96*SD. These values, referred
to as the 'limits of agreement', have standard errors of
approximately V(3SD2 n-1), where n is the sample size (Bland
& Altman, 1986).
Results
Glomerularfiltration rate (GFR), iohexolfluorescence
technique
The GFR values obtained from the slope (GFR3) ranged
from 15 to 144 ml min ' 1.73 m2, mean: 76.4 ± 4.89
(± SEM). The values obtained from one-point estimation
(GFR,) ranged from 15 to 150 ml min-' 1.73 m-2, mean
78.2 ± 4.93. The correlation coefficient from linear regression
analysis was 0.98 (Table II). The mean difference between
GFRI and GFR3 was 1.7 ml min' 1.73m2, standard devia-
tion 5.4 ml min ' 1.73 m-2, giving lower and upper limits of
agreement of - 8.8 and 12.2 ml min ' 1.73 m-2, respectively
(Table III).
Table II Renal function variables in 34 patients with urogenital
cancer
Regression a ± SEa b ± SEb SY.X r
GFRI on GFR3 3.04 ± 2.63 0.98 ±0.032 5.4 0.982
Cl", on GFR3 8.71 ± 5.94 0.83 ± 0.073 12.2 0.894
ClMh,pp on GFR3 0.46 ± 6.62 1.00 0.081 13.6 0.907
Clpn0r on Clest 1.60 ± 4.69 0.96 ± 0.061 9.5 0.940
ClMhjpp on Cl0,, 1.46 ± 7.63 1.04 0.100 15.5 0.879
CIMhipp on Clpnor 13.2 ± 9.9 0.89± 0.131 20.7 0.769
Least square linear regression; model: Y = (a ± SE.) + (b ± SEb)*X.
GFR, and GFR3: Glomerular filtration rate (GFR) investigation by
iohexol fluorescence one-point analysis and slope, respectively. ClO,,:
Creatinine clearance estimated from serum creatinine on day ofGFR
investigation. Clpnor: Creatinine clearance from serum creatinine
measured 1-3 days before GFR investigation. Clh,pp: Hippuran
clearance. ClMhpp: Clipp divided by 5.01, see text. sy.X: Square root of
the mean square of residuals with 32 degrees of freedom denotes the
amount of variability in the dependent variable (Y) not explained by
the estimated model. All variables in ml min- 1.73 m2.
Table III Comparison of renal function variables in 34 patients
with urogenital cancer
Limits of agreement
Variables D SD Lower Upper 95% CI
GFR, on GFR3 1.7 5.4 - 8.8 12.2 ± 1.6
Cl., on GFR3 -3.9 13.0 -29.4 21.6 ± 7.8
ClMh,pp on GFR3 0.4 13.4 - 26.7 25.9 + 8.0
Clprior on Cl,,, - 1.2 9.4 - 19.7 17.3 ± 5.6
ClU, on ClMhipp - 4.4 15.2 - 34.3 25.5 ± 9.0
Clprior on ClMhipp - 5.3 20.6 - 46.0 34.8 ± 12.2
D: Mean of differences between variables. SD: Standard deviation
of D. Lower and upper limits of agreement (95% level):
D ± 1.96*SD*95% CI: 95% confidence interval for the agreement
limit, 33 degrees of freedom. All variables in ml min' 1.73 m-2, see
Table II for abbreviations.
Hippuran clearance
The Hippuran clearance (Clhipp) was from 147 to 776 ml
min-' 1.73 m2, mean 381 ± 27.4ml min~' 1.73m2. The
best fit linear function by least square regression of Clhipp on
GFR3 was: Clhipp = (2.2 ± 33.1) + GFR3. (5.01 ± 0.41). The
square root of the mean square of residuals (sy.,): with 32
degrees of freedom (d.f.) was 68.2 ml min-' 1.73m2. This
parameter denotes the amount ofvariability in the dependent
variable (Clh,pp) not explained by the estimated model. The
correlation coefficient (r) was 0.907. To further test the rela-
tionship between ClEpp and GFR3, the series was divided in
two equally large subseries, consisting ofthe patients with the
17 lowest and the 17 highest GFR3 values, respectively.
Analysis of variance (ANOVA) on the squared residuals
from the regression analysis indicated no significant
difference between the subseries (F-ratio 0.004, 1 d.f.,
P>0.95). Thus, we found no evidence that the residuals
were dependent on the absolute GFR3 value. For the data
from the 17 patients with GFR3 values from 15 to
74 ml min-' 1.73m2, the best fit linear function was:
Clhpp= (28.1 ± 55.9) + GFR3e(4.50 ± 1.03),
with sy.x = 64.9 ml min-' 1.73 m2, 15 d.f., r = 0.746.
The best fit linear function for the 17 patients with GFR3
values from 76 to 144mlmin'- 1.73 m2 was:
Clpp (-27.8 ± 110.4) + GFR3. (5.31 ± 1.09),
with sY.X = 74.8 ml min-' 1.73 m2, 15 d.f., r = 0.781 (Figure 1).
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Figure 1 For the 17 patients with GFR3 values from 15 to
74 ml min-' 1.73 m2 (white dots) the regression line was
r = 0.746, thin line, and for the 17 patients with GFR3 values
from 76 to 144 ml min-' 1.73 m2 (black dots) 0.781, bold line.
These regression lines were not significantly different from each
other or from the common regression line (dotted).
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Although the r-value improved (from <0.8 to >0.9) when
the data from all patients were combined, sy.x did not im-
prove. This illustrates the value of considering the residuals
when comparing data by means of regression analysis
(Snedecor & Cochran, 1980). The r-value alone may give a
false impression of consistency.
To assess the agreement between GFR3 and Clhipp and to
allow other comparisons as well, the Clhipp values were
divided by 5.01 (the regression coefficient estimated for all 34
patients) to obtain the ClMhpp (Table II and Table III).
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The creatinine clearance estimated from the first blood sample
(Clprior) ranged from 29 to 132 ml min-' 1.73 m2, mean
70.5±4.73mlmin-' 1.73m-2, and from 28 to 123ml
min-' 1.73 m-2, mean 71.8 ± 4.63 ml min-' 1.73 m-2 for the
second sample (Cl,,t). The mean of differences, standard
deviations and lower and upper limits of agreement are
shown in Table III and Figure 2.
Creatinine clearance estimated concurrently with the GFR
investigation (Cl,1t) and previously (Clprior) was compared
with GFR and Hippuran clearance. The results from linear
regression analysis are listed in Table II. The mean of the
differences, their standard deviations and the limits of agree-
ment with 95% confidence intervals are demonstrated in
Table III. A scatterplot of Cl., vs GFR3 is shown in Figure
3a with limits of agreement in Figure 3b.
Discussion
Smith and colleagues were the first to fully exploit the possi-
bilities of clearance methods to quantify GFR and renal
plasma flow (Smith et al., 1949). Normally about 120 ml of
filtrate are separated from the 600 ml of plasma passing
through the kidneys each minute, which implies a plasma
flow to GFR ratio of about 5 to 1 (de Wardener, 1985). The
proportionality coefficient of 5.01 ± 0.41 between Hippuran
clearance and GFR measured by iohexol fluorescence is close
to this ratio and confirms the link between glomerular and
tubular function embodied in the 'intact nephron hypothesis'
(Bricker et al., 1960). Since the extraction fraction for Hip-
puran is very high, 80-90%, the Hippuran clearance is often
referred to as the 'effective renal plasma flow'. However,
substances which compete with Hippuran for transport on
-
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Figure 3a Scatterplot of glomerular filtration rate measured with
the iohexol fluorescence technique (GFR3) and creatinine
clearance estimated from serum creatinine sampled at the same
time (Cl551). b difference against mean for estimated creatinine
clearance and GFR3, from a. Upper and lower limits of agree-
ment
- 29.4 and 21.6 ml min-' 1.73 m-2 respectively, with 95%
confidence intervals (boxed areas) of ± 7.8 ml min-' 1.73 m2.
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the tubular level also reduce the Hippuran extraction fraction
(Maisey et al., 1983). In the presence of such substances, for
example cisplatin, the Hippuran clearance will underestimate
+40- kidney function. The GFR does not rely on tubular transport
and is preferred under such circumstances. The one point
measurement of iohexol clearance (GFR,) agreed well with
the slope (GFR3). However, when using one cannula for
±20 . * injection and blood sampling, tracer contamination can be
l - revealed only by using more than one sample.
. . The present study mutually compared GFR, Hippuran
* . clearance and creatinine clearance estimated from serum
0. * . - - creatinine values. The average error were close to zero (Table
o- -
-- - III). In some patients with discrepancy was nevertheless sub-
*. . . * * stantial and could have had clinical consequence. Variability
* in renal function studies may be due to methodological error.
Inaccuracy in the measurement of injected and sampled
20 * tracer and X-ray contrast has been estimated to be respon-
sible for a 4.5% difference for 5"Cr-EDTA and 7.8% for
X-ray contrast (Sjoberg et al., 1987). Discrepancy may also
arise from biological differences; in physical activity, in the
intake of food and fluids, and from variations in blood
-40 _ I pressure and renal blood flow. The impact of these factors is
50 100 150 Du difficult to assess, and their minimisation probably requires
Mean of Clprior and Clest (ml min-' 1.73 m-2) strict patient regimens which may be hard to fulfill in clinical
e 2 Difference against mean for estimated creatinine settings. In the present series some young patients with testi-
ance from serum creatinine obtained on different days (Clpor cular cancer had higher serum creatinine levels in the first
Ces,). Lower and upper limits of agreement were - 19.7 and sample. It could be assumed that these patients had had a
mlmin- 1.73 m2, respectively, with 95% confidence inter- higher level of physical activity and/or a liberal intake of
boxed area) of ± 5.6 ml min-I 1.73 m-2. cooked meat before admission. Serum creatinine levels may
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increase substantially after eating cooked meat (Jacobson et
al., 1979) and following exercise (Statland et al., 1973). We
have observed serum creatinine levels rising transiently to
more than twice the upper reference limit following general-
ised epileptic seizures in patients without kidney disease
(unpublished data). Some elderly patients had low creatinine
levels initially, perhaps reflecting poor nourishment before
admission. This could explain why the discrepancy between
the Hippuran clearance and the initial creatinine clearance
estimation (Clpjor) was greater than between the Hippuran
clearance and the creatinine clearance estimated from blood
sampled the same day (Cl,,t), (Table III). For inpatients there
is less variation in exercise and the composition ofmeals. We
therefore suspect that the differences will be even greater in
outpatients who are investigated at any time during the day.
Estimations of renal function imply the assumption of
steady state conditions during the sampling period. The trad-
itional reference method, the inulin clearance, has a standard
deviation amounting from 5 to 7% of the mean when
meticulous techniques are used (Davies & Shock, 1950).
Comparing the precision and reproducibility of 51Cr-EDTA,
estimated creatinine clearance and measured creatinine
clearance, Brochner-Mortensen et al. (1976) concluded that
5"Cr-EDTA is the method of choice. However, the cyclotron-
produced tracer 5tCr is less readily available than 9'9Tc which
also allows imaging of the urinary tract. GFR measurements
using 99'Tc-DTPA is in widespread clinical use (Mulligan et
al., 1990). In our institution six to eight blood samples during
3 h have been necessary to obtain a reliable result (unpub-
lished data). Moreover, DTPA binding to plasma proteins
may be a source of error (Russell et al., 1983).
O Reilly et al. (1986) correlated findings in 33 patients,
under controlled conditions in a urology unit. The correla-
tion coefficient between measured creatinine and 5"Cr-EDTA
clearances, was r = 0.69 (considered as unsatisfactory) while
the correlation between 5"Cr-EDTA and X-ray contrast
medium clearances was r = 0.90 (good). However, the pres-
ent results demonstrate that when two methods of clinical
measurements are compared in terms of the correlation
coefficient only (r, Table II), unrealistic impressions of con-
sistency may result. It is more useful clinically to know how
much the measurement with one method is likely to differ
from that obtained with the other, as is expressed by the
limits of agreement (Bland & Altman, 1986). This approach
is relatively new, and we have therefore compared the limits
of agreement from the present study (Table III) with those
which can be calculated from other reports. Effersoe et al.
(1990) correlated GFR by the iohexol method and the 5"Cr-
EDTA clearance in 15 patients and obtained r = 0.95. How-
ever, from their Table II the GFR values with the iohexol
method were on the average 10.8 ml min-' 1.73 m-2 higher
(significantly greater than 0). The standard deviation of the
differences was 7.9 ml min-' 1.73m2, which implies lower
and upper agreement limits of about - 5 ml min-' 1.73 m-2
and about 25 ml min-' 1.73 m-2, respectively. Sj6berg et al.
(1987) investigated 21 patients and compared GFR values
obtained with metrizoate and 51Cr-EDTA. From their
tabulated data (Sj6berg et al., 1987, Table I) the mean
difference between the methods was approximately 3 ml
min'1 1.73 m-2, with standard deviation 10 ml min-' 1.73 m-2.
Hence, the limits of agreement were - 17 ml min-' 1.73 m-2
and 23 ml min-' 1.73 m-2, respectively. Lewis et al. (1989)
found r = 0.86 for X-ray contrast clearance and inulin
clearance measurements. From their tabulated data (Lewis et
al., 1989, Table I) the mean difference between the methods
was 0.7 ml min' 1.73 m2, with standard deviation 17.7 ml
min-' 1.73 m2. This yields limits of agreement of about
- 34 and about 36 ml min-' 1.73 m-2. Thus, the present
limits of agreement are in the same range as those which can
be calculated from the data from other studies. Our findings
therefore seem to give a representative account of kidney
function tests. To measure glomerular filtration rate within
limits of less than ± 15-20 ml min-' 1.73m2 seems not
realistic, except, conceivably, under meticulously standardised
regimens which may be difficult to implement in routine
work. These considerations could be clinically important if
nephrotoxic therapy guided by the individual patient's kidney
function is contemplated.
Conclusions
Creatinine clearance estimations based on the serum
creatinine level is subject to the influence from the patient's
muscle mass, physical activity and intake of cooked meat.
The Hippuran clearance will underestimate kidney function
in the presence of substances which compete with Hippuran
for transport on the tubular level, for example cisplatin. The
GFR method does not rely on tubular transport and is
therefore the preferred method under such circumstances.
lohexol clearance with stable iodine and fluorescence tech-
nique is a cost effective mean to assess GFR. Using stable
iodine allows almost infinite storage of standard solutions
and patient samples. Thus, instrumentation and procedures
can be controlled for quality and consistency when the need
arises. This is difficult using a decaying radiotracer.
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